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Abstract— Wheezing is common among children and ~50% of 
those under 6 years of age are thought to experience at least one 
episode of wheeze. However, due to the heterogeneity of symptoms 
there are difficulties in treating and diagnosing these children. 
‘Phenotype specific therapy’ is one possible avenue of treatment, 
whereby we use significant pathology and physiology to identify 
and treat pre-schoolers with wheeze. By performing feature 
selection algorithms and predictive modelling techniques, this 
study will attempt to determine if it is possible to robustly 
distinguish patient diagnostic categories among pre-school 
children. Univariate feature analysis identified more objective 
variables and recursive feature elimination a larger number of 
subjective variables as important in distinguishing between 
patient categories. Predicative modelling saw a drop in 
performance when subjective variables were removed from 
analysis, indicating that these variables are important in 
distinguishing wheeze classes. We achieved 90%+ performance in 
AUC, sensitivity, specificity, and accuracy, and 80%+ in kappa 
statistic, in distinguishing ill from healthy patients. Developed in a 
synergistic statistical - machine learning approach, our 
methodologies propose also a novel ROC Cross Evaluation 
method for model post-processing and evaluation. Our predictive 
modelling's stability was assessed in computationally intensive 
Monte Carlo simulations. 
Keywords— wheeze, pre-school, feature selection, predictive 
modelling, ROC analysis, model post-processing, Monte Carlo 
I.  INTRODUCTION 
Wheeze, described as a high-pitched whistling sound 
emitted during expiration [1], [2], is common among children of 
pre-school age. It is thought that around 50% of pre-schoolers 
(up to age 6) will have at some point experienced at least one 
episode of wheeze [3]. Compared with older age groups, pre-
schoolers with wheeze have been shown to have a 50% greater 
need for assistance by ambulance, just under twice the number 
of emergency response (ER) visits and almost three-times the 
rate of hospitalization [4]. With previous estimates placing the 
cost of care for pre-schoolers with wheeze at around 0.15% of 
the healthcare budget in the UK, further burden is being placed 
on already stretched healthcare resources [5]. In this study, we 
will examine a ‘phenotype specific therapy’ as one possible 
avenue of diagnosis of wheeze in children of pre-school age 
using meaningful symptom clusters and significant pathology 
and physiology to identify different groups of pre-schoolers with 
wheeze leading to appropriate treatment.  
Diagnosing wheeze in pre-schoolers is fraught with 
difficulty due to the heterogeneity in the timing and 
manifestation of co-occurring symptoms. In surveys conducted 
within European populations, only 83.5% of parents could 
correctly identify an episode of wheeze [6]. Specifically, within 
the UK, 33% of parents after watching recordings of children 
with wheeze concluded their child did not actually suffer from 
episodes [7]. While the presentation of symptoms and family 
history of atopy are useful in an initial investigation, they are 
only an indication of diagnosis; a trial of steroids may be given 
but there is no certainty they will relieve the child of symptoms 
[13], [14]. Furthermore, lung function tests are not routinely 
performed in young children. While it is possible to undertake 
other measurements of pre-school children in a primary care 
setting, such as peak flow, these may require trained technicians 
and specialised laboratory equipment. 
The diagnosis of wheeze in pre-school children is further 
complicated by the heterogeneity of wheeze development over 
time. There have been several approaches to classify wheeze 
phenotypes in pre-school age children with wheeze. One 
approach has been to divide children into atopic and non-atopic 
groups based on ‘early aeroallergen sensitisation’ [11]. 
Henderson et al’s [8] study investigating the association between 
pre-school age wheezing phenotype and environmental 
influences on the development of asthma identified six wheeze 
phenotypes which reflect the heterogeneity in evolution of 
wheeze symptoms over time [9], [10].  
Due to the complexities involved in asthma diagnosis in 
early childhood, conditions presenting with wheeze may lead to 
over- or under-diagnoses [15]. This has been acknowledged in 
global guidelines and reports on childhood asthma identifying 
the difficulty of diagnosis in children of pre-school age [1], [16]–
[18]. The symptom may be considered indicative of asthma and, 
therefore, treated with courses of inhaled corticosteroids (ICS), 
resulting in the child developing significant steroidal side effects 
[19].  Under-diagnosis results in the absence of suitable and 
appropriate therapy [20]. 
Due to this heterogeneity of wheeze and difficulty in 
distinguishing patterns over time, ‘phenotype specific therapy’ 
[21] has been suggested as a possible approach for a more 
stratified approach to wheeze diagnosis and management 
strategies. The aim is to eventually phenotype children and drive 
individualised therapy based on the combination of the 
identification of meaningful symptom clusters and significant 
pathology and physiology. In this study, we hypothesise that 
using feature selection and prediction modelling techniques on 
biomarkers will enable us to identify groups regarding the 
presence and the stage of wheeze condition in pre-schoolers. We 
use data from a cohort of children with pre-school wheeze (PSW 
cohort) from the Royal Brompton Hospital (RBH) to test this 
hypothesis.  
II. METHODS 
A. Description of study population 
The RBH has collected clinical data from children of pre-
school age since 2010, resulting in the PSW cohort. The dataset 
obtained from this group of children contains information on 
150 patients for 636 variables. 61% of patients are male with a 
cohort mean age of 33.66 months (SD 16.82). 72% of patient 
data pertains to pre-schoolers who have been seen historically 
and are currently being followed-up.  The remainder pertains to 
recently seen and documented patients. 
B. Description of variables 
The variables in the PSW cohort can be broadly separated 
into:   
 Baseline Demographics (such as gender, age, ethnicity) 
 Subjective clinical data obtained from the parents at the 
patients first research contact (such as current household 
smoking status, location of home and family history of 
asthma). 
 Objective clinical data collected at the patients first 
research contact, and the first, one year and final follow-
up appointments. These include whether the patient has 
recurrent chest infections, persistent cough or upper 
airway problems.  
 Biological data collected at the patients first research 
contact (such as skin prick allergy test results, pH probe 
to detect level of acid present, blood tests). 
In the PSW cohort, clinicians have identified 4 categories 
(referred to as ‘Group’ variable in the dataset) of patient based 
on clinical presentation: Wheeze (patient with wheeze), 
Wheeze+ (patient with wheeze and some other respiratory issue 
i.e. rattly chest), Clean Controls (patient with upper airway 
problem but no lower airway issue) and Diseased Controls 
(patient without wheeze but has other respiratory issue i.e. 
presumed chest infection). In this study, the Control categories 
have been merged in to a single Control category. 
C. Statistical and machine learning methods 
A synergistic combination of statistical and machine 
learning techniques was used in this study to identify and 
employ significant biomarkers in effectively distinguishing 
between different categories of the ‘Group’ variable. Techniques 
used to achieve this aim included feature selection methods such 
as univariate feature analysis, recursive feature elimination, 
principal component analysis (PCA), the RelieF method, as well 
as SMOTE, permutation tests, Chi-squared test, ROC analysis, 
etc. Supervised learning algorithms including feed-forward 
neural networks (NN), support vector machines (SVM), and 
random forests (RF), accompanied the above methods towards 
this aim. 
D. Data cleaning 
Extensive data cleaning was undertaken to ensure the 
harmonisation of data collected historically and more recently. 
For certain variables, the coding method between both data sets 
differed. For example, string notation such as ‘moisturiser’, 
‘steroid cream’ and ‘both’ had been used to record eczema 
treatment for patients who had been seen historically, however, 
numeric coding (such as 0, 1, 2) had been implemented for 
recent patients.  
Variables with less than 25% complete cases, describing 
open-ended questions, or categorical data where one response 
category contained less than 5% of the data were removed. A 
further 21 variables were discarded as they were considered less 
likely to provide useful or additional information during 
analysis. This resulted in a total of 89 variables being retained. 
As the sample size for this study was modest, variables with 3 
or more categories were collapsed into dichotomous categories.  
E. Imputation 
 Patterns of missing data were initially assessed using the 
‘misschk’ package [22] in Stata [23]. Missing values were then 
imputed using the Stata package ‘ice’[24], which performs 
multivariate imputation using chained equations. To implement 
multivariate imputation for missing data, 26 variables that were 
found to be collinear with other variables were identified and 
removed. After the data had been cleaned with missing values 
imputed, 63 variables including the ‘Group’ variable were 
retained for further analysis. Of the 63 retained, some variables 
relevant for this paper are described in Table I. 
F. Feature selection 
In order to identify variables with strong associations to the 
‘Group’ variable, feature selection techniques including 
univariate feature analysis, recursive feature elimination and 
PCA were used on the PSW dataset.  A chi-squared 
classification test for non-negative features was used on each 
variable in univariate analysis to determine which features of the 
dataset have been identified as having prominent relationships  
to the outcome ‘Group’ variable.   
Four separate analyses were conducted with different 
outcome pairs; each Group class against the remaining classes 
referred to as ‘Other’ with a final test for Wheeze+ against 
Wheeze (see Table II). These four pairs of outcomes were also 
used in the recursive feature elimination analysis. Logistic 
regression models were created on a training set of data (that was 
then used on test data) before then discarding the 10% weakest 
features. This is then repeated until model accuracy significantly 
diminishes.   
G. Principal component analysis 
To reduce the number of redundant variables, PCA was 
implemented on the PSW dataset. As the dataset contained a 
large number of dichotomous and continuous variables, a 
variation of PCA was performed using the R CRAN package 
‘PCAmixdata’[25]. This employs both PCA and multiple  
TABLE I.  DESCRIPTION OF SOME RELEVANT RETAINED VARIABLES                      
A. NOMINAL VARIABLES. B. CONTINUOUS VARIABLES. 
 
correspondence analysis (MCA) to accommodate both types of 
data. The principal component scores obtained were then 
regressed on Group classes Wheeze+, Wheeze and Control to 
determine if there was a significant association between patient 
categories and principal component (PC) scores. 
H. Predictive modelling 
The methodology developed for predicting a diagnosis for 
patients is discussed in this section, and was coded in R using 
‘caret’ for parallel predictive model training and tuning, ‘pROC’ 
for ROC analysis, and other R libraries required by ‘caret’.  
We built our methodology upon various algorithms which 
require and do not require external feature selection, such as 
back propagation for feed-forward neural networks and support 
vector machines, and random forests, respectively. As validation 
techniques, we employed simple and nested cross validation 
(CV), and in some variants of our methodology for the 2-class 
problems we performed post-processing of the predictive 
models based on alternative optimal cutoff points found on 
multiple ROC curves. These post-processing methods are also a 
solution for the class imbalance problem in the 2-class 
classification in our framework. A pre-processing method, 
SMOTE [26], which generates synthetic observations based on 
interpolations between an observation and its neighbours, is 
alternatively used to balance the training data, and is considered 
separately or in conjunction with the model post-processing 
methods. In addition to the data imbalance, a second issue in our 
framework is the relatively small size of the data (150 
observations). This small size may become a challenge in a 
predictive modelling approach in which we employ two cross 
validations (as it is the case in nested CV) for model tuning and 
validation, and a model post-processing. As such, we propose a 
novel model post-processing and evaluation method, called 
ROC Cross Evaluation (ROC-CE), to address this issue.   
Finally, we performed comparisons and studied the stability of 
the performances of various predictive models built in different 
variants of our methodology, via computationally intensive 
Monte Carlo (MC) simulations with 1000 experiments each. 
Each of the classification problems were considered on two 
versions of the dataset. The first dataset, which we call the  
reduced dataset, comprises 47 variables containing objectively 
measured predictors, and the second dataset, which we call the 
mixed dataset, comprises 62 variables containing objective and 
subjective predictors. In particular, the reduced dataset was 
investigated in the context of the clinical lead to see how good a 
performance in diagnoses can be reached on objective variables 
only, and how it compares to diagnoses made on the objective 
and subjective variables from the mixed dataset. 
III. RESULTS 
A. Missing data 
A preliminary investigation of the dataset found that only 2 
patients (1.33%) had complete data, with over a third of patients 
(35%) missing data for 20 or more variables.  
B. Feature analysis 
Table III shows results from univariate feature analysis. 
MBL, Total IgE, Pneumoccocus and BAL neutrophils gave the 
highest chi-squared statistic, indicating a strong relationship 
with each set of diagnostic outcome pairs.   
The five strongest features identified with recursive feature 
elimination using the 62 retained variables from the PSW dataset 
A. 
Variable Description (%) in Categories 
Group 
'Control' (0), 
'Wheeze' (1) or 
'Wheeze+' (2) 
0 (24.00%), 1 
(36.67%), 2(39.33%) 
Exposure to pets at 
home (currently) No (0), Yes (1) 0 (64.67%), 1 (35.33%) 
Family history of 
eczema No (0), Yes (1) 0 (42.67%), 1 (57.33%) 
Gender Girl (0), Boy (1) 0 (39.33%), 1 (60.67%) 
Ever admitted to 
hospital with wheeze No (0), Yes (1) 0 (32.67%), 1 (67.33%) 
Has your child ever 
wheezed No (0), Yes (1) 0 (21.33%), 1 (78.67%) 
How many episodes 
in the past 6 months ≤3 (0), >3 (1) 0 (38.00%), 1 (62.00%) 
Infant feeding Other (0), Breast (1) 0 (52.67%), 1 (47.33%) 
Persistent cough No (0), Yes (1) 0 (62.67%), 1 (37.33%) 
PSW (Pre-school 
wheeze) No (0), Yes (1) 0 (31.33%), 1 (68.67%) 
Recurrent chest 
infections No (0), Yes (1) 0 (72.00%), 1 (28.00%) 
B. 
Variable Description Mean SD 
BAL 
neutrophils 
(%) RBH 
Neutrophils cell percentage (out 
of total cell count) from 
bronchoalveolar lavage 
undertaken by RBH 
26.61 22.20 
HDM iU Skin prick allergy test 12.54 23.22 
Macrophages 
(%) RBH 
Macrophages cell percentage (out 
of total cell count) undertaken by 
RBH 
54.12 23.08 
MBL Mannose-binding lectin 2569.69 1622.19 
Pneumococcus 
result 
Test for pneumococcal antibodies 108.91 102.19 
Total IgE Immunoglobulin E 118.39 227.77 
 
against the four pairs of diagnostic outcomes are displayed in 
Table III. ‘Recurrent chest infections’ was identified as the 
strongest feature in the models with dependent outcome 
(Wheeze+, Other), (Wheeze, Other) and (Wheeze+, Wheeze) 
with ‘PSW’ the strongest feature with dependent outcome 
(Control, Other).   
TABLE II.  PAIRS OF OUTCOMES USED IN FEATURE ANALYSIS 
 
 
 
 
TABLE III.  UNIVARIATE FEATURE ANALYSIS AND RECURSIVE FEATURE 
ELIMINATION RESULTS USING 62 RETAINED VARIABLES FROM PSW DATASET    
C. Principal component analysis 
After conducting PCA on the PSW dataset, it was 
determined that 23 principal components had eigenvalues 
greater than (or equal to) one. Reducing the dataset to these 
principal components ensured that 79.5% of the original 
variance exhibited by the data was accounted for. Individuals 
were then assigned principal component scores.  
The principal components (with their scores) were then used 
in three logistic regression analyses against the patient 
diagnostic outcomes (Control, Wheeze), (Control, Wheeze+), 
(Wheeze, Wheeze+). The key findings were: 
 In regression analysis conducted with (Control, Wheeze) 
as the dependent variable, PC4 which loads heavily onto 
‘Eosinophils’ and ‘Eosinophils percentage’ and PC21 
which loads heavily on to ‘Location of home’ were found 
to be statistically significant risk ORs.  
 When (Control, Wheeze+) was regressed on by each 
principal component, PC3 (risk factor) which loads 
heavily on to ‘BAL neutrophils RBH’ and ‘Macrophages 
RBH’ and PC14 (protective factor) which loads heavily 
on to ‘Total IgG’ was found to have produced statistically 
significant ORs, respectively. 
 PC2 which loads heavily on to ‘Height’, ‘Age (months)’, 
‘Weight’ and PC14 which loads heavily on to ‘Total IgG’ 
were found to produce statistically significant protective 
ORs with (Wheeze, Wheeze+) as the dependant variable. 
D. Predictive modelling 
In the 3-class problem based on Control, Wheeze and 
Wheeze+ classes, we tuned RF, NN and SVM models in 10-fold 
CV. Models such as NN and SVM are sensitive with a tendency 
of decreasing their performance in presence, in the dataset, of 
less-predictive or non-predictive variables in addition to the 
predictive ones, while RF models are robust from this point of 
view [29]. As such, when building the NN and SVM models, we 
applied a feature selection procedure based on the RelieF 
method [28] combined with a permutation test [27] conveniently 
implemented by using 2000 random permutations. 
 
 
 
Fig. 1. Relief predictive power of 62 features, with 16 predictors crossing the 
horizontal blue line corresponding to 1.96 standard deviations, selected for 
model training. 
Test Outcome 
Test 1 Wheeze+, Other 
Test 2 Wheeze, Other 
Test 3 Control, Other 
Test 4 Wheeze+, Wheeze 
 
A. WHEEZE+, OTHER 
Univariate Feature Analysis Recursive Feature Elimination 
Variables Score Variables Score 
MBL 1154.00 Recurrent chest infections 1 
Total IgE 685.10 PSW 2 
HDM iU 134.40 IgM 3 
Pneumococcus result 131.10 Persistent cough 4 
BAL neutrophils (%) RBH 35.68 Exposure to pets at home (currently) 5 
B. WHEEZE, OTHER 
Univariate Feature Analysis Recursive Feature Elimination 
Variables Score Variables Score 
MBL 13120.00 Recurrent chest infections 1 
Total IgE 3480.00 PSW 2 
Pneumococcus result 308.10 Persistent cough 3 
BAL neutrophils (%) RBH 127.50 Infant feeding 4 
Macrophages (%) RBH 46.60 Ever admitted to hospital with wheeze 5 
C. CONTROL, OTHER 
Univariate Feature Analysis Recursive Feature Elimination 
Variables Score Variables Score 
MBL 8167.00 PSW 1 
Total IgE 1341.00 Has your child ever wheezed 2 
HDM iU 86.62 Recurrent chest infections 3 
Pneumococcus result 45.02 How many episodes in the past 6 months 4 
BAL neutrophils (%) RBH 34.90 Family history of eczema 5 
D. WHEEZE+, WHEEZE 
Univariate Feature Analysis Recursive Feature Elimination 
Variables Score Variables Score 
MBL 7674.00 Recurrent chest infections 1 
Total IgE 1990.00 Persistent cough 2 
Pneumococcus result 271.90 IgM 3 
BAL neutrophils (%) RBH 99.22 Ever admitted to hospital with wheeze 4 
HDM iU 61.18 Gender 5 
 
The features having an observed Relief score at least 1.96 
standard deviations away from the centre of the normal 
distribution of the Relief scores obtained, for each feature, by 
randomly permuting the classes of the observations, have been 
selected as predictors for model training.  The number of 
standard deviations away of each feature’s observed Relief 
score, from the centre of the above distribution, defines, in our 
approach, the ‘Relief predictive power’ of that feature. The 
‘Relief predictive power’ is illustrated for all the 62 features in 
the bar chart in Fig. 1, with 16 predictors crossing the horizontal 
blue line corresponding to 1.96 standard deviations. The idea 
here, inspired by the permutation tests [27], is that the features 
having observed Relief scores larger than 95% of Relief scores 
(all in absolute value) obtained by randomly shuffling the 
classes, are considered predictive.  Variables such as ‘PSW’ 
(Relief predictive power = 27) and ‘Recurrent chest infections’ 
(Relief predictive power = 11.8) are among the top 3 predictors. 
By applying the feature selection method above, the best NN 
model was based on one single hidden layer with 20 nodes and 
a weight decay of 0.4 for L2 regularization, and led to an 
accuracy of 0.828 (SD 0.012) with a 95% confidence interval 
95%CI [0.805, 0.849], and the kappa statistic of 0.736 (SD 
0.019). The best SVM model was based on the radial kernel, had 
the hyper-parameters cost C=4, and gamma=0.002, and led to 
similar performances of accuracy of 0.830 (SD 0.011) with 
95%CI [0.807 0.852], and of kappa statistic of 0.742 (SD 0.017). 
Finally, the best RF model, built on all the 62 features, was based 
on 1000 trees with mtry (the number of predictors competing in 
a tree node at a time) equal to 20, and achieved an accuracy of 
0.817 (SD 0.015) with a 95%CI [0.787, 0.846] and a kappa 
statistic of 0.722 (SD 0.023). As mentioned above, the models’ 
performances stability was studied with 1000 experiment based 
MC simulations. Given the 3-class classification and the high 
kappa values, these models with equivalent performance are 
judged as good, but perhaps not good enough to use them in a 
diagnosing process. As such we transformed the 3-class problem 
in multiple 2-class problems as mentioned above. 
The methodology that we developed for the 2-class problems 
involved a higher complexity due to two joint aspects of the data, 
namely of being imbalanced (for instance 36 Control versus 114 
Wheeze and Wheeze+), and of being relatively small (150 
observations). We fully illustrate the methodology, with some of 
its developed variants, on the Control versus Other (i.e. Wheeze 
and Wheeze+) problem, which is one of the most important 2-
class classification problems here. We then provide the results 
of the prediction modelling performed on the other 2-class 
classification problems. 
   Our approach consisted of tuning and evaluating NN, SVM 
and RF models in a nested CV, formed of a 10-fold inner CV, 
and 4-fold outer CV (results in outer 3-fold CV were obtained, 
but they were statistically comparable and not reported here), 
with extra operations encapsulated. The solution we adopted for 
the class imbalanced data was based on optimising the area 
under curve, AUC, in the inner CV, corroborated with applying 
two optimisation methods on ROC curves in the outer CV. The 
first such a method is based on determining the point on the ROC 
which is the closest to the top-left point of coordinates (0,1) 
which represents an ideal model with both sensitivity and 
specificity equal to 1 (see Fig. 2 for illustrated ROC curves). The 
second optimisation method is based on the Youden’s J statistic 
[31] whose largest value corresponds to the cutoff point on the 
ROC, maximizing the sum of the sensitivity and specificity, or 
maximizing the distance to the main diagonal. Both cutoff points 
represent an alternative to the default 0.5 cutoff point for the 
classification probability, which usually leads to a disproportion 
between sensitivity and specificity in case of class imbalance. 
Using the closest top-left cutoff or youden cutoff balances 
sensitivity and specificity [29]. For instance, Table IV 
summarises a MC simulation consisting of 1000 experiments, 
each of which producing a tuned RF model with AUC 
optimisation in the inner 10-fold CV, which was post-processed 
using the closest top-left cutoff method and evaluated in the 
outer 4-fold CV. 
As such, according to our methodology, a validation fold in 
the outer CV is used in both – the post-processing of the model 
by determining and applying a new cutoff point for classification 
probabilities, and in evaluating the model by applying a tailored 
method that we introduce here, called ROC Cross Evaluation, or 
ROC-CE. It is a recommended requirement the model 
evaluation to be performed on a dataset which is different from 
the dataset used for generating the ROC curve employed in 
determining an optimal cutoff.  
TABLE IV.  BEST MODEL IDENTIFIED FOR CONTROL VS OTHER WITH 
MIXED DATASET OF 62 FEATURES:  OPTIMISED RF’S PERFORMANCES WITH 95% 
CONFIDENCE INTERVAL’S LEFT AND RIGHT ENDS 
 
ROC-CE is designed to make the ROC based model post-
processing and evaluation also possible for small datasets, 
although in such cases usually data is insufficient to detach from 
it a new dataset for model evaluation. In ROC-CE we take a 
validation fold D in the outer CV, and split it into a number of k 
sub-folds. In order to score the observations in a hold-out sub-
fold L of D, we use all the other k-1 sub-folds of D to build a 
ROC curve, on which we determine the closest top-left or 
youden cutoff point, that we then apply to get the post-processed 
model that in turn is used to produce predictions for the 
observations in L. We repeat this for each hold-out sub-fold in 
D, and aggregate predictions to finally produce the performance 
evaluation on fold D. The principle of ROC-CE is somehow 
similar to that of cross validation, but instead of model training 
and validation, the model post-processing and evaluation take 
place based on determining and using optimised cutoffs on 
multiple ROCs. In the case of our dataset, which is small, each 
hold-out sub-fold L of D was formed of one observation only.  
Table IV shows a good balance between the sensitivity of 
0.927 (the detection rate of Wheeze and Wheeze+ patients) and 
a specificity of 0.915 (the detection rate of Controls) of the best 
RF model tuned and evaluated in a nested CV with the ROC-CE 
method based on the closest top-left cutoff point (similar 
 
 Mean SD ci95left ci95right 
AUC 0.981 0.007 0.965 0.991 
Sens 0.927 0.018 0.895 0.965 
Spec 0.915 0.030 0.861 0.972 
Accuracy 0.924 0.017 0.893 0.960 
Kappa 0.802 0.043 0.723 0.892 
 
performances have been obtained with the youden cutoff). The 
stability of the performances of this best model overall, was as 
usually studied within 1000 MC experiments. SVM and NN best 
models were obtained in the same way. RF was better with 2% 
in average accuracy and 5% in average kappa than the SVM 
model, and with 1% in average accuracy and 3% in average 
kappa than the much more computationally expensive NN best 
model. The use of the SMOTE method [26] as an alternative to 
ROC-CE for the class imbalance, led to a 4% imbalance between 
sensitivity (0.936) and specificity (0.9) on tuned RF models, 
with comparable performances to those in Table IV. We 
conclude that the performance levels of RF model in Table IV 
makes it suitable in establishing if a patient suffers of a wheeze 
condition. 
The same methodology was applied to the other 2-class 
classifications with analyses on Wheeze VS Other, Wheeze+ VS 
Other, and Wheeze+ VS Wheeze. In the first 2-class 
classification, the best model was an optimised SVM with radial 
kernel tuned in a nested CV with 10-fold inner CV, 
TABLE V.  BEST MODELS IDENTIFIED FOR 2-CLASS CLASSIFICATIONS 
WITH MIXED DATASET OF 62 FEATURES. A. OPTIMISED SVM’S PERFORMACES 
FOR WHEEZE VS OTHER. B. OPTIMISED SVM’S PERFORMANCE FOR WHEEZE+ VS 
OTHER. C.  RF’S PERFORMANCES FOR WHEEZE+ VS WHEEZE. 
 
4-fold outer CV, and post-processed and estimated in ROC-CE 
with the closest top-left method. Variation/ stability of the model 
performances were investigated in a MC simulation of 1000 
experiments, with performances shown in Table V (Part A). The 
best model with the second 2-class classification was an 
optimised SVM with radial kernel, tuned in a nested CV with 
10-fold inner CV, 4-fold outer CV, and post-processed and 
estimated in ROC-CE with the closest top-left method. 
Variation/ stability of the model were investigated with MC 
(1000 experiments), with performance shown in Table V (Part 
B). With the third 2-class classification, the best model was RF 
with mtry=20 obtained and evaluated in 10-fold CV with 
SMOTE technique applied on the training folds. MC 
performances are shown in Table V (Part C). 
The results show good performance levels in distinguishing 
each single group Wheeze or Wheeze+ from each other, or from 
the other 2 groups together. In particular, Wheeze+ patients are 
detected in proportion of 87% by excluding controls from the 
analysis (see sensitivity in Table V Part C). In this case, we 
achieve an 85% accuracy. The detection of Wheeze+ patients 
among the whole cohort of subjects is 81% with an accuracy of 
82%, and the detection of wheeze patients among the whole 
cohort is 80% with an accuracy of 82% (see Table V Parts B and 
A, resp.). Naturally, the highest performances were obtained in 
Control VS Other, whose results were presented in Table IV. 
A question of clinical interest was if at least the same level 
of prediction performance and performance stability can be 
achieved by utilising only the objective features. To investigate 
this problem, we applied the same methodology (with its 
variants) to the Control VS Other classification problem (which 
led to the best prediction performance as shown in Table IV) on 
the reduced dataset with objective predictors. The resulting best 
model was obtained again with RF, that was tuned and evaluated 
in a nested CV with the ROC-CE method based on the closest 
top-left cutoff point. Comparing the performances of the best 
models built on the mixed and reduced datasets, which are 
illustrated in Tables IV and VI, respectively, we conclude that 
all the prediction performances decreased drastically, namely 
with 22% for AUC, 23% for sensitivity, 27% for specificity, 
24% for accuracy, and 52% for kappa when using the objective 
features only. The model stability decreased also as suggested 
by the increase of the standard deviations of performances, or by 
the length of the 95% confidence intervals estimated in the 1000 
MC experiments aggregated in Tables IV and VI. In conclusion, 
subjective variables are extremely useful in accurately 
classifying patients when added to the objective variables. 
TABLE VI.  BEST MODEL IDENTIFIED FOR CONTROL VS OTHER WITH 
RDUCED DATASET OF 47 OBJECTIVE FEATURES:  OPTIMISED RF PERFORMANCES 
 
Let us note also that, just removing the subjective ‘PSW’ 
predictor alone from the mixed dataset, (feature which was 
scored with the highest Relief predictive power as illustrated in 
Fig.1), led, for the RF model built for the 3-class problem, to a 
decrease of accuracy with 11%, and a decrease of kappa statistic 
with 18%. On the other hand, results show that in the 2-class 
Control VS Other problem, by removing the ‘PSW’ predictor 
alone, the prediction performances of the best RF models 
decreased with 10% for AUC, 9% for sensitivity, 17% for 
specificity, 10% for accuracy, and 26% for kappa. The triple 
ROC chart in Fig. 2 illustrates a loss of prediction pattern, in the 
Control VS Other problem, of the 62 feature mixed dataset 
(black ROC) by removing first the ‘PSW’ predictor (blue ROC),  
A. 
 Mean SD ci95left ci95right 
Sens 0.796 0.029 0.745 0.855 
Spec 0.836 0.027 0.779 0.884 
Accuracy 0.821 0.023 0.773 0.860 
Kappa 0.622 0.046 0.526 0.704 
B.  
 Mean SD ci95left ci95right 
Sens 0.805 0.030 0.746 0.864 
Spec 0.821 0.028 0.758 0.879 
Accuracy 0.815 0.023 0.767 0.853 
Kappa 0.618 0.046 0.523 0.7 
C.  
 Mean SD ci95left ci95right 
Sens 0.871 0.015 0.843 0.900 
Spec 0.822 0.025 0.770 0.863 
Accuracy 0.848 0.015 0.816 0.875 
Kappa 0.694 0.029 0.631 0.747 
 
 
 Mean SD ci95left ci95right 
AUC 0.758 0.029 0.701 0.812 
Sens 0.695 0.049 0.603 0.793 
Spec 0.644 0.054 0.528 0.750 
Accuracy 0.683 0.041 0.599 0.763 
Kappa 0.281 0.070 0.142 0.421 
 
and then removing all the other subjective features (red ROC). 
 
Fig. 2. Decrease in area under curve AUC for best RF models from using the 
mixed dataset (black ROC) to removing the ‘PSW’ predictor  (blue ROC), then 
to removing all subjective variables and using the reduced dataset (red ROC). 
IV. DISCUSSION AND CONCLUSION 
In this study, we proposed that by utilising a variety of 
different statistical, feature analysis and predictive modelling 
techniques, it would be possible to identify groups within the 
PSW dataset by their pathology and clinical markers.    
By first comparing the results from the univariate feature 
analysis and recursive feature elimination, it is clear that each 
provides a unique insight into which biomarkers are thought to 
be strongly associated with each pair of patient diagnostic 
outcomes. While MBL features highly in the univariate feature 
outcome tables, it is noticeably absent from the list of strongly 
associated variables that were produced through recursive 
feature elimination. Recurrent chest infection appears to be 
strongly associated with all pairs of ‘Group’ class outcomes in 
the recursive feature results but comparatively are not seen in the 
highest univariate feature chi-squared classification scores. The 
most stark difference is apparent when comparing each set of 
results between both feature selection analysis where there are 
no shared variables between the top five strongest feature lists.  
When regressing the 23 PCs identified against the pairs of 
‘Group’ classes, PC2 was found to be a protective factor and 
PC17 a risk factor for dependent variable (Wheeze+, Wheeze). 
These principal components load heavily on to variables 
pertaining to Height, Age (months), Weight and MBL inferring 
that these biomarkers could be useful in distinguishing between 
Wheeze and Wheeze+ patient classes.   
A key finding from the prediction modelling performed on 
the mixed dataset and the reduced dataset containing only 
objective variables was the dramatic drop in prediction 
performance in the latter set. This suggests that the subjective 
variables are important in distinguishing ill patients from 
controls, particularly the ‘PSW’ variable which, when removed 
alone, resulted in a significant drop in prediction power. 
To our knowledge, the study has used the largest number of 
clinical and pathology orientated variables using unsupervised 
and predictive modelling techniques in an attempt to distinguish 
if any markers are significant in determining pre-school wheeze 
class. By confirming physician-diagnosed groups or, 
alternatively, identifying new clusters of patients, care and 
therapy for these patients could in the future be tailored using 
significant biomarkers as a guide for treatment.  A clear strength 
of this study is its breadth of analysis; in using multiple 
investigative methods to assess the dataset, various features 
associated with different wheeze classes can be determined. 
An important limitation of this study was the level of missing 
data. After cleaning the data, patients were, on average, missing 
25% of data. Although this is a common issue with clinical 
datasets and was addressed through multivariate imputation, the 
severity of missing data must be taken into consideration when 
analysing and interpreting results. As a result of discarding 
variables with less than 25% cases or in a format unsuitable for 
analysis, all data relating to follow-up appointments for patients 
was withheld from analysis (as only 18 of the 135 follow up 
variables fulfilled the data retention criteria, they were not 
included).  
While PCA is a useful tool for reducing the number of 
variables while retaining a high level of overall data variability, 
this does result in a steep reduction of variability among certain 
variables which are not largely accounted for among the 
generated PCs. This could result in certain patterns and 
relationships between variables and, consequently, patient 
classes becoming lost or misinterpreted in results.  
Our predictive modelling best results show we achieved 
90%+ performance in AUC, sensitivity, specificity, and 
accuracy, and 80%+ in kappa statistic in distinguishing ill from 
healthy patients (Control VS Other classification). The 
predictive modelling was developed in a synergistic statistical - 
machine learning approach, and our methodologies incorporate 
a novel method that we proposed for predictive model post-
processing and evaluation, called ROC Cross Evaluation. The 
latter works on all dataset sizes, but it is particularly useful when 
there is not enough data for model training, tuning, post-
processing and/or evaluation/testing on independent data, as in 
the case of our relatively small dataset of 150 instances. The 
predictive models we developed were based on algorithms such 
as random forests, support vector machines, and back 
propagation for feed-forward neural networks. We performed 
comparisons and studied the stability of the performances of 
various predictive models built in different variants of our 
methodology, via a computationally intensive Monte Carlo 
simulation with 1000 experiments (each of which comprising all 
the phases of the methodology including model training, tuning 
and post-processing). This large volume of computation has 
been achieved by performing a parallel processing in R on a 
computer cluster formed of 11 servers based on Xeon processors 
and 832GB of fast RAM. 
Ongoing work concerns, on one hand, the extension of our 
methodologies with a clustering approach. On the other hand, 
one of the aims of this work was to optimise prediction 
performance rather than develop supervised models with 
explanatory power, and as such, in this study we favoured 
algorithms with larger flexibility in adapting to the data, even 
though they were based on black box approaches. A natural 
extension of this work is to develop supervised models with 
explanatory power that would attempt to match, as much as 
possible, the prediction performance of the black box supervised 
models developed here. This is a natural extension as clinicians 
favour models with explanatory power in certain aspects of their 
research, especially when understanding the link between 
predictors and outcome is the primary goal.   
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